Global health R&D

At a glance

How much funding is available?

Public funding for global health research and development (R&D) stood at US$2.3 billion in 2017, according to Policy Cures Research’s G-FINDER report. This marks the second year of increasing investments (+8% compared to US$2.1 billion in 2016) and accounted for two-thirds of total funding (65%). The remaining third came from philanthropic contributions (19%) and the private sector (16%).

Global Health R&D General

For further details on methodology, see our Donor Tracker Codebook.

Who are the top donor countries?

Public funding for global health R&D is concentrated among a few donors. In 2017, the US provided two-thirds of all public funding, US$1.6 billion. The second-largest donor was the UK (US$186 million, 8% of all funding), followed by EU institutions (US$119 million, 5%). For the second year in a row, India was the fourth-largest donor (US$76 million, 3%), and was followed by Germany (US$65 million, 3%).